OraSure, Targeted Genomics in pact for at-home celiac genetic testing

May 14, 2025 10:03 AM ETOraSure Technologies, Inc. (OSUR) StockBy: Nilanjana Basu, SA News Editor
(<1min)
Businesspeople making handshakes, while standing on painted pattern on asphalt

Klaus Vedfelt

  • Targeted Genomics LLC on Wednesday announced a commercial collaboration with OraSure Technologies (NASDAQ:OSUR) which manufactures ORAcollect·Dx, a saliva collection device approved for general over-the-counter use.
  • Targeted Genomics markets GlutenID, an FDA-cleared direct-to-consumer test to detect the genetics of celiac disease, the world's

Recommended For You

More Trending News

About OSUR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
OSUR--
OraSure Technologies, Inc.